Lv3
258 积分 2023-02-20 加入
EGFR and HER2 exon 20 insertions in solid tumours: from biology to treatment
3天前
已完结
Familial endometrial cancer in female carriers of MSH6 germline mutations
12天前
已完结
Novel rearrangements involving the RET gene in papillary thyroid carcinoma
2个月前
已完结
Acquired MET-DSTN Fusion Mediated Resistance to EGFR-TKIs in Lung Adenocarcinoma and Responded to Crizotinib Plus Gefitinib: A Case Report
2个月前
已完结
Detection of ALK and KRAS Mutations in Circulating Tumor DNA of Patients With Advanced ALK-Positive NSCLC With Disease Progression During Crizotinib Treatment
3个月前
已完结
Detection of ALK and KRAS Mutations in Circulating Tumor DNA of Patients With Advanced ALK-Positive NSCLC With Disease Progression During Crizotinib Treatment
3个月前
已完结
Improving the efficacy of anti-EGFR drugs in GBM: Where we are going?
4个月前
已完结
Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel
4个月前
已完结
Amivantamab plus chemotherapy with and without lazertinib in EGFR-mutant advanced NSCLC after disease progression on osimertinib: primary results from the phase III MARIPOSA-2 study
4个月前
已完结
Identifying novel oncogenic RET mutations and characterising their sensitivity to RET-specific inhibitors
5个月前
已关闭
皖公网安备34019202002308
